Abstract
Children and adolescents who have developmental or behavioral differences (DBD) may present with the same range of nonorganic functional symptoms as otherwise typical young people. Paradoxically, DBD may itself be a nonorganic functional symptom. The presence of DBD may introduce potential pitfalls in the assessment and management of functional symptoms, leading to incomplete or erroneous conclusions and inappropriate interventions. Some specific nonorganic functional symptoms are more likely to present in children with developmental differences (DD) compared to typically developing children. Children who have behavioral differences (BD), particularly autism spectrum disorder, are more likely to present with functional symptoms than their neurotypical peers. Failure to take DBD into account often leads to hasty and incomplete evaluation of symptoms and consequent failure to address key underlying problems. An approach to diagnosis and treatment which takes DBD into account is likely to lead to the best outcome for the affected child and family. Included in this discussion are several symptoms which are, strictly speaking, not functional symptoms but which occur more often in association with DBD than in typical people. These symptoms may be ameliorated with effective management of the underlying DBD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Powell GF, Brasel JA, Blizzard RM. Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. 1. Clinical evaluation of the syndrome. N Engl J Med. 1967;276(23):1271–8.
Cole SZ, Lanham JS. Failure to thrive: an update. Am Fam Physician. 2011;83(7):829–34.
Genero A, Moretti C, Fait P, Guariso G. Non-organic failure to thrive: retrospective study in hospitalized children. Pediatr Med Chir. 1996;18(5):501–6.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Skuse DH. Non-organic failure to thrive: a reappraisal. Arch Dis Child. 1985;60(2):173–8.
Brooks-Gunn J, Duncan GJ. The effects of poverty on children. Future Child. 1997;7(2):55–71.
Raikes HA. Poverty and development in low-income Nicaraguan children. Interam J Psychol. 2005;39(3):399–412.
Kaler SR, Freeman BJ. Analysis of environmental deprivation: cognitive and social development in Romanian orphans. J Child Psychol Psychiatry. 1994;35(4):769–81.
Miljkovitch M. Developmental delay, anxiety, deprivation and neglect: psychodynamics of a case of new problems. Ann Med Psychol (Paris). 1993;151(6):441–52.
Richters MM, Volkmar FR. Reactive attachment disorder of infancy or early childhood. J Am Acad Child Adolesc Psychiatry. 1994;33(3):328–32.
Boris NW, Zeanah CH, Larrieu JA, Scheering MS, Heller SS. Attachment disorders in infancy and early childhood: a preliminary investigation of diagnostic criteria. Am J Psychiatry. 1998;155(2):295–7.
Hornor G. Reactive attachment disorder. J Pediatr Health Care. 2008;22(4):234–9.
Rutter M, Andersen-Wood L, Beckett C, Bredenkamp D, Castle J, Groothues C, Kreppner J, Keaveney L, Lord C, O’connor TG. Quasi-autistic patterns following severe early global privation. J Child Psychol Psychiatry. 1999;40(4):537–49.
Beckett C, Maughan B, Rutter M, Castle J, Colvert E, Groothues C, Kreppner J, Stevens S, O’connor TG, Sonuga-Barke EJ. Do the effects of early severe deprivation on cognition persist into early adolescence? Child Dev. 2006;77(3):696–711.
Rudolf MC, Logan S. What is the long term outcome for children who fail to thrive? A systematic review. Arch Dis Child. 2005;90(9):925–31.
Behen ME, Muzik O, Juhasz C, Nagy F, Chugani DC. Local brain functional activity following early deprivation: a study of post institutionalized Romanian orphans. Neuroimage. 2001;14(6):1290–301.
Eluvathingal TJ, Chugani HT, Behen ME, Juhász C, Muzik O, Maqbool M, Chugani DC, Makki M. Abnormal brain connectivity in children after early severe socioemotional deprivation: a diffusion tensor imaging study. Pediatrics. 2006;117(6):2093–100.
Bye AME, Kok DJM, Ferenschild FTJ, Vles JSH. Paroxysmal nonepileptic events in children: a retrospective study over a period of 10 years. J Paediatr Child Health. 2000;36:244–8.
Kuyk J, Leijten F, Meinardi H, Spinhoven P, Van Dyck R. The diagnosis of psychogenic non-epileptic seizures: a review. Seizure. 1997;6(4):243–53.
Reuber M. Psychogenic non-epileptic seizures: diagnosis, aetiology, treatment and prognosis. Schweiz Arch Neurol Psychiatr. 2005;156(2):47–57.
Irwin K, Edwards M, Robinson R. Psychogenic non-epileptic seizures: management and prognosis. Arch Dis Child. 2000;82(6):474–8.
Beck JE. A developmental perspective on functional somatic symptoms. J Pediatr Psychol. 2008;33(5):547–62.
Peterson CC, Palermo TM. Parental reinforcement of recurrent pain: the moderating impact of child depression and anxiety on functional disability. J Pediatr Psychol. 2004;29(5):331–41.
Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011;168(9):904–12.
Taylor PG. A beginners guide to the autism spectrum disorders: essential information for parents and professionals. London: Julia Kingsley; 2011.
Weisbrot DM, Gadow KD, DeVincent CJ, Pomeroy J. The presentation of anxiety in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2005;15(3):477–96.
Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47(8):921–9.
Towbin KE, Pradella A, Gorrindo T, Pine DS, Leibenluft E. Autism spectrum traits in children with mood and anxiety disorders. J Child Adolesc Psychopharmacol. 2005;15(3):452–64.
Wood JJ, Drahota A, Sze K, Har K, Chiu A, Langer DA. Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: a randomized, controlled trial. J Child Psychol Psychiatry. 2009;50(3):224–34.
Sofronoff K, Attwood T, Hinton S. A randomised controlled trial of a CBT intervention for anxiety in children with Asperger syndrome. J Child Psychol Psychiatry. 2005;46(11):1152–60.
Namerow LB, Thomas P, Bostic JQ, Prince J, Monuteaux MC. Use of citalopram in pervasive developmental disorders. J Dev Behav Pediatr. 2003;24(2):104–8.
Henry CA, Steingard R, Venter J, Guptill J, Halpern EF, Bauman M. Treatment outcome and outcome associations in children with pervasive developmental disorders treated with selective serotonin reuptake inhibitors: a chart review. J Child Adolesc Psychopharmacol. 2006;16(1–2):187–95.
Couturier JL, Nicolson R. A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2002;12(3):243–8.
Taylor PG. The effectiveness of medical self-hypnosis in reducing anxiety in people with high functioning autism. Research Presentation. Edge Hill University, May, 2010. http://www.edgehill.ac.uk/documents/health/conferences/communication/PaulTaylor.pdf Last accessed on 13 Dec 2012.
Keen DV. Childhood autism, feeding problems and failure to thrive in early infancy. Seven case studies. Eur Child Adolesc Psychiatry. 2008;17(4):209–16.
Bergman RL, Piacentini J, McCracken JT. Prevalence and description of selective mutism in a school-based sample. J Am Acad Child Adolesc Psychiatry. 2002;41(8):938–46.
Gillberg C. Asperger syndrome in 23 Swedish children. Dev Med Child Neurol. 1989;31(4):520–31.
Kristensen H. Selective mutism and comorbidity with developmental disorder/delay, anxiety disorder, and elimination disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(2):249–56.
Firooz A, Firoozabadi MR, Ghazisaidi B, Dowlati Y. Concepts of patients with alopecia areata about their disease. BMC Dermatol. 2005;5:1.
Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev. 2008;16(2):CD004413
van den Biggelaar FJ, Smolders J, Jansen JF. Complementary and alternative medicine in alopecia areata. Am J Clin Dermatol. 2010;11(1):11–20.
Tay YK, Levy ML, Metry DW. Trichotillomania in childhood: case series and review. Pediatrics. 2004;113(5):e494–8.
Franklin ME, Zagrabbe K, Benavides KL. Trichotillomania and its treatment: a review and recommendations. Expert Rev Neurother. 2011;11(8):1165–74.
Hanna GL. Trichotillomania and related disorders in children and adolescents. Child Psychiatry Hum Dev. 1997;27(4):255–68.
Lochner C, du Toit PL, Zungu-Dirwayi N, Marais A, van Kradenburg J, Seedat S, Niehaus DJ, Stein DJ. Childhood trauma in obsessive-compulsive disorder, trichotillomania, and controls. Depress Anxiety. 2002;15(2):66–8.
Franklin ME, Edson AL, Freeman JB. Behavior therapy for pediatric trichotillomania: exploring the effects of age on treatment outcome. Child Adolesc Psychiatry Ment Health. 2010;4(18):1753–2000.
Sukhodolsky DG, Scahill L, Zhang H, Peterson BS, King RA, Lombroso PJ, Katsovich L, Findley D, Leckman JF. Disruptive behavior in children with Tourette’s syndrome: association with ADHD comorbidity, tic severity and functional impairment. J Am Acad Child Adolesc Psychiatry. 2003;42(1):98–105.
Reiersen AM, Todd RD. Co-occurrence of ADHD and autism spectrum disorder: phenomenology and treatment. Expert Rev Neurother. 2008;8(4):657–69.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Taylor, P.G. (2014). Functional Symptoms in Children Who Have Developmental or Behavioral Differences. In: Anbar, R. (eds) Functional Symptoms in Pediatric Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4899-8074-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4899-8074-8_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4899-8073-1
Online ISBN: 978-1-4899-8074-8
eBook Packages: MedicineMedicine (R0)